1. Home
  2. ELTX vs ACOG Comparison

ELTX vs ACOG Comparison

Compare ELTX & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • ACOG
  • Stock Information
  • Founded
  • ELTX 2011
  • ACOG 2000
  • Country
  • ELTX United States
  • ACOG Canada
  • Employees
  • ELTX N/A
  • ACOG N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • ACOG
  • Sector
  • ELTX Health Care
  • ACOG
  • Exchange
  • ELTX Nasdaq
  • ACOG Nasdaq
  • Market Cap
  • ELTX 158.5M
  • ACOG 149.0M
  • IPO Year
  • ELTX N/A
  • ACOG N/A
  • Fundamental
  • Price
  • ELTX $9.13
  • ACOG $5.88
  • Analyst Decision
  • ELTX Strong Buy
  • ACOG Strong Buy
  • Analyst Count
  • ELTX 1
  • ACOG 1
  • Target Price
  • ELTX $13.00
  • ACOG $18.00
  • AVG Volume (30 Days)
  • ELTX 102.3K
  • ACOG 107.1K
  • Earning Date
  • ELTX 11-07-2025
  • ACOG 11-13-2025
  • Dividend Yield
  • ELTX N/A
  • ACOG N/A
  • EPS Growth
  • ELTX N/A
  • ACOG N/A
  • EPS
  • ELTX N/A
  • ACOG N/A
  • Revenue
  • ELTX N/A
  • ACOG $4,586,341.00
  • Revenue This Year
  • ELTX N/A
  • ACOG N/A
  • Revenue Next Year
  • ELTX N/A
  • ACOG $101.16
  • P/E Ratio
  • ELTX N/A
  • ACOG N/A
  • Revenue Growth
  • ELTX N/A
  • ACOG N/A
  • 52 Week Low
  • ELTX $4.60
  • ACOG $3.75
  • 52 Week High
  • ELTX $12.62
  • ACOG $11.54
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 34.25
  • ACOG 30.97
  • Support Level
  • ELTX $9.03
  • ACOG $6.55
  • Resistance Level
  • ELTX $9.55
  • ACOG $6.95
  • Average True Range (ATR)
  • ELTX 0.46
  • ACOG 0.49
  • MACD
  • ELTX -0.04
  • ACOG -0.07
  • Stochastic Oscillator
  • ELTX 9.65
  • ACOG 33.80

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: